Sovran Advisors, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 2051471 SAN DIEGO, CA

Position in REGN

as of Mar 31, 2026 · filed May 1, 2026 Compact

Position Value

$4,650,520

-$2,002,227 QoQ

Shares Held

6,019

-30.2% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

1.14%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2025

4 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Sovran Advisors, LLC holds $5,991,448 across 3 Biotechnology names. REGN ranks #1 (77.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc. This page	6,019	$4,650,520
2	GALT	Galectin Therapeutics Inc	257,830	$719,345
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,392	$621,583

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,650,520	6,019	-30.2%	Shares	Sole	2026-05-01
2025-12-31	$6,652,747	8,619	-22.6%	Shares	Sole	2026-01-20
2025-09-30	$6,262,563	11,138	+121.9%	Shares	Sole	2025-10-31
2025-06-30	$2,635,500	5,020	—	Shares	Sole	2025-07-10
No filing history on record for this holder in this stock.